The neurotensin receptor-1 pathway contributes to human ductal breast cancer progression - Test2 - elhamkhani - TriplyDB

The neurotensin receptor-1 pathway contributes to human ductal breast cancer progression

The neurotensin receptor-1 pathway contributes to human ductal breast cancer progression

http://www.wikidata.org/entity/Q33401257

about

Neurotensin receptor-1 inducible palmitoylation is required for efficient receptor-mediated mitogenic-signaling within structured membrane microdomains The calcineurin/NFAT pathway is activated in diagnostic breast cancer cases and is essential to survival and metastasis of mammary cancer cells.Recursive Random Lasso (RRLasso) for Identifying Anti-Cancer Drug Targets Suicide HSVtk gene delivery by neurotensin-polyplex nanoparticles via the bloodstream and GCV Treatment specifically inhibit the growth of human MDA-MB-231 triple negative breast cancer tumors xenografted in athymic mice.Diverse expression patterns and tumorigenic role of neurotensin signaling components in colorectal cancer cells.Neurotensin receptor 1 is expressed in gastrointestinal stromal tumors but not in interstitial cells of Cajal.Characterization of the substrate specificity of human carboxypeptidase A4 and implications for a role in extracellular peptide processing.Association between genetic subgroups of pancreatic ductal adenocarcinoma defined by high density 500 K SNP-arrays and tumor histopathology Suppression of neurotensin receptor type 1 expression and function by histone deacetylase inhibitors in human colorectal cancers.Activation of EGFR, HER2 and HER3 by neurotensin/neurotensin receptor 1 renders breast tumors aggressive yet highly responsive to lapatinib and metformin in mice.Neurotensin (NTS) and its receptor (NTSR1) causes EGFR, HER2 and HER3 over-expression and their autocrine/paracrine activation in lung tumors, confirming responsiveness to erlotinib.Genome-wide association of breast cancer: composite likelihood with imputed genotypes Individual variation of the genetic response to bisphenol a in human foreskin fibroblast cells derived from cryptorchidism and hypospadias patients A marine analgesic peptide, Contulakin-G, and neurotensin are distinct agonists for neurotensin receptors: uncovering structural determinants of desensitization properties Imatinib mesylate enhances the malignant behavior of human breast carcinoma cells.The significance of NTR1 expression and its correlation with β-catenin and EGFR in gastric cancer.Evaluation of DOTA-chelated neurotensin analogs with spacer-enhanced biological performance for neurotensin-receptor-1-positive tumor targeting Neurotensin and its high affinity receptor 1 as a potential pharmacological target in cancer therapy SR48692 inhibits non-small cell lung cancer proliferation in an EGF receptor-dependent manner Neurotensin, a Novel Messenger to Cross-Link Inflammation and Tumor Invasion via Epithelial-Mesenchymal Transition Pathway.Differential expression and tumorigenic function of neurotensin receptor 1 in neuroendocrine tumor cells.A Review of the Role of Neurotensin and Its Receptors in Colorectal Cancer.The potential of neurotensin secreted from neuroendocrine tumor cells to promote gelsolin-mediated invasiveness of prostate adenocarcinoma cells.The Internalization of Neurotensin by the Low-Affinity Neurotensin Receptors (NTSR2 and vNTSR2) Activates ERK 1/2 in Glioma Cells and Allows Neurotensin-Polyplex Transfection of tGAS1.Expression of neurotensin receptor 1 in endometrial adenocarcinoma is correlated with histological grade and clinical outcome.Validation of Neurotensin Receptor 1 as a Therapeutic Target for Gastric Cancer.

P2860

Q24310096-FF65844F-2C40-4B9E-87F0-A188CDA2BCA2 Q27330253-601DB376-4190-4F2D-95E6-928C44318191 Q28550739-E01A7AC3-D4B3-4D4A-99D7-9825600CBFE7 Q33604560-9E930BD8-BDE5-42A0-BF18-7000A5BEB822 Q33699404-E114872B-78DF-44C2-BF91-9B33F9E81CA6 Q33833577-BB9C1D54-1A3B-4653-A5D0-0FD8019E5767 Q33897773-9BCB8966-1F56-4B24-A5B9-280AB0611DB9 Q33979834-60C1FC21-FD10-4A34-A436-5E6A3F4305FB Q34100964-6038E3DC-AC15-403A-87FC-C490E7A56BF8 Q34483533-BD859672-E14A-4485-8501-4A7EA426401C Q34483541-D1B3012E-A568-415A-B13A-6C4E4FF4391D Q34514955-65C63CE8-6F39-4C28-A155-1AF56E26A7CC Q34534556-1B7855C8-62E0-4080-9218-FFDB0A0D3B4B Q35066670-44C4D1D0-EF60-42E2-8E4F-4144024587C5 Q35739389-018E3422-F7E5-41ED-B9AF-68EBA32B3495 Q35895961-D5942643-7A77-46A6-9276-AE364CC61D11 Q36122563-EEC06286-4FB6-4996-A65F-6383BCBED637 Q36540348-58F103AC-26D4-467F-9977-938B5B74F2F1 Q37662776-C887BFE5-686D-41E0-BE0E-1C19392512DF Q38248621-F0D8FC65-CCC0-4F8F-BDD5-204D5BFE265C Q38841614-C3422081-D742-450F-992D-F364C7C6479F Q38895540-C9908B02-3F3C-4B0F-AE7B-4EB33048C8DE Q38920728-A2E80F9D-FA0A-4F26-BF6C-13F0F6C9B1BD Q41221061-B2B3A7AB-8513-4A6A-9C6E-1C3B6BB25B18 Q47912978-63B39505-657F-44F3-A6BF-3C8C7B16BA0C Q55427672-C777E906-A7A5-408F-9D5A-93FFC2A9014E

P2860

The neurotensin receptor-1 pathway contributes to human ductal breast cancer progression

http://www.wikidata.org/entity/Q33401257

description

2009 nî lūn-bûn

@nan

2009 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

The neurotensin receptor-1 pathway contributes to human ductal breast cancer progression

@ast

The neurotensin receptor-1 pathway contributes to human ductal breast cancer progression

@en

type

label

The neurotensin receptor-1 pathway contributes to human ductal breast cancer progression

@ast

The neurotensin receptor-1 pathway contributes to human ductal breast cancer progression

@en

prefLabel

The neurotensin receptor-1 pathway contributes to human ductal breast cancer progression

@ast

The neurotensin receptor-1 pathway contributes to human ductal breast cancer progression

@en

P1433

Q33401257-B4042FA7-EF00-47D9-886D-97DD854DEAEE

P1476

Q33401257-796ACC54-43E7-48F4-8893-EC7018561174

P2093

Q33401257-18C4E576-BCD8-43C6-B9B6-258B32109104

Q33401257-2A96AF46-1997-4791-9F6F-6D56BB7FC5B2

Q33401257-3D803117-A6EF-4E20-9E81-43D31A937CB4

Q33401257-5622F461-03D4-4D20-8D9B-FD8E5C12E788

Q33401257-63E740BD-803F-448F-909E-7616E28CD46E

Q33401257-90F92F3B-86DB-4487-815F-A58FC2C7A401

Q33401257-A01CAA2F-B4DA-4635-9576-E9F1DCB8DEB0

Q33401257-A67CA79F-A21D-42F4-B4C8-D391DDB65A62

Q33401257-ABA8B9D3-D2BC-401D-A51E-778DFA5D465B

Q33401257-B0F4BB65-5071-48D1-A843-2699E464FC1A

P2860

Q33401257-0428D06E-ED70-4D05-83EA-9DD0D3E885B4

Q33401257-0630CA78-6765-4B7A-824C-A32BFEF03539

Q33401257-0844E19B-823E-4529-A42D-76FE236A5A14

Q33401257-0B8A74C1-615A-4AF8-8F08-31C27A31EA09

Q33401257-329D55DE-F624-4BA2-93ED-2E6809C48878

Q33401257-33BC9F0E-C596-4738-8F6C-671035F0B13E

Q33401257-34598EC5-9BD7-409D-988D-81536CF1859D

Q33401257-3C97650B-066D-4FA9-AF28-72C20F922C16

Q33401257-554BE8E3-FF01-40B0-837C-455708ACE377

Q33401257-5BC62985-259D-4C23-97A7-65FB0603A389

P304

Q33401257-C7B16F9F-A8E8-4A55-92C4-6102F2B1CB0A

P31

Q33401257-C3F4DC8E-A2F6-4A48-BDC4-E465D0CBFBF8

P356

Q33401257-8E7BE15A-7F78-4F40-B304-563386D20DF7

P407

Q33401257-BAFC23B6-A4FB-4E62-9E5A-A78F5CF8B09A

P433

Q33401257-7183316F-55B7-4C5A-B851-FB3CACD77E8F

P478

Q33401257-E830F764-7B8D-4B50-9FA8-455E2A7E0EE0

P50

Q33401257-06867FDF-E98A-48FB-B88D-6FF968663A1A

P577

Q33401257-4DFEE488-06D7-412D-B81E-EFA619B1E099

P5875

Q33401257-5B53D920-0339-4AD0-81F4-78495A743B69

P698

Q33401257-A1D03741-E24B-42DC-852F-D7F94B363420

P932

Q33401257-77855538-8698-4B84-B561-EBA75C1FE384

P356

JOURNAL.PONE.0004223

P1433

P1476

The neurotensin receptor-1 pathway contributes to human ductal breast cancer progression

@en

P2093

Anne Gompel

http://www.w3.org/2001/XMLSchema#string

Anne Lavaur

http://www.w3.org/2001/XMLSchema#string

Christian Gespach

http://www.w3.org/2001/XMLSchema#string

Danielle Hugol

http://www.w3.org/2001/XMLSchema#string

Frédérique Souazé

http://www.w3.org/2001/XMLSchema#string

Geneviève Plu-Bureau

http://www.w3.org/2001/XMLSchema#string

Marc Chaouat

http://www.w3.org/2001/XMLSchema#string

Marco Alifano

http://www.w3.org/2001/XMLSchema#string

Patricia Forgez

http://www.w3.org/2001/XMLSchema#string

Sandra Dupouy

http://www.w3.org/2001/XMLSchema#string

P2860

Cloning and expression of a complementary DNA encoding a high affinity human neurotensin receptor

Neurotensin causes tyrosine phosphorylation of focal adhesion kinase in lung cancer cells

Neurotensin counteracts apoptosis in breast cancer cells

Estrogen-inducible neurotensin immunoreactivity in the preoptic area of the female rat

DNA methylation contributes to expression of the human neurotensin/neuromedin N gene

Genomic and transcriptional aberrations linked to breast cancer pathophysiologies

Gene expression profiling in breast cancer: understanding the molecular basis of histologic grade to improve prognosis

Receptor trafficking via the perinuclear recycling compartment accompanied by cell division is necessary for permanent neurotensin cell sensitization and leads to chronic mitogen-activated protein kinase activation.

Neurotensin phosphorylates GSK-3alpha/beta through the activation of PKC in human colon cancer cells

Neurotensin and growth of normal and neoplastic tissues.

P304

e4223

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0004223

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

4

http://www.w3.org/2001/XMLSchema#string

P50

Geneviève Plu-Bureau

P577

2009-01-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23804046

http://www.w3.org/2001/XMLSchema#string

P698

19156213

http://www.w3.org/2001/XMLSchema#string

P932

2626627

http://www.w3.org/2001/XMLSchema#string